Patent ID: 7749993

Claim:
A method for treating severe heart failure of New York Heart Association Class III and IV to reduce a risk of mortality, comprising administering to a patient in need thereof an amount therapeutically effective to reduce the risk of mortality of a benzazepine compound of formula (1): wherein R 1 is a hydrogen atom or a halogen atom, R 2 is a hydroxy group, or a group of the formula: —NR 5 R 6 wherein R 5 and R 6 the same or different and are each a hydrogen atom or a C 1 -C 6 alkyl group, R 3 is a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl group, or a C 1 -C 6 alkoxy group, R 4 is a halogen atom, a C 1 -C 6 alkyl group or a C 1 -C 6 alkoxy group, or a pharmaceutically acceptable salt thereof.